Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High Risk
100%
Low Risk
100%
Acute Lymphoblastic Leukemia
100%
Second Cancer
100%
Standard Risk
50%
Maintenance Therapy
37%
Hazard Ratio
25%
Adjusted Hazard Ratio
25%
Thiopurine Methyltransferase
25%
ETV6-RUNX1
25%
White Blood Cell Count
12%
Low Activity
12%
Working Diagnosis
12%
Survival Rate
12%
Improved Survival
12%
Clinical Remission
12%
Childhood Acute Lymphoblastic Leukemia
12%
High Hyperdiploidy
12%
BCP-ALL
12%
Methyltransferase Activity
12%
Pediatric Oncology
12%
Pediatric Hematology
12%
Cancer Hazard
12%
Thiopurines
12%
Thiopurine Therapy
12%
Subset Analysis
12%
Biochemistry, Genetics and Molecular Biology
ETV6
100%
RUNX1
100%
Thiopurine Methyltransferase
100%
Leukocyte Count
50%
High Risk Population
50%
Precursor
50%
B Cell
50%
Survival Rate
50%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Second Cancer
100%
Hazard Ratio
50%
Maintenance Therapy
37%
Mercaptopurine
25%
Thiopurine Methyltransferase
25%
Cell Count
12%
Leukocyte
12%
High Risk Population
12%
Survival Rate
12%
Precursor
12%
B Cell
12%
Pediatric Oncology
12%
Pediatric Hematology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Second Cancer
100%
Acute Lymphoblastic Leukemia
100%
Thiopurine Methyltransferase
25%
Mercaptopurine
25%
Remission
12%
Survival Rate
12%